ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.

PHASE4TerminatedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Salmeterol

DRUG

Fluticasone Propionate/Salmeterol Combination Product

Trial Locations (11)

19107

GSK Investigational Site, Philadelphia

19140

GSK Investigational Site, Philadelphia

27704

GSK Investigational Site, Durham

30030

GSK Investigational Site, Decatur

32610

GSK Investigational Site, Gainesville

35294

GSK Investigational Site, Birmingham

52242

GSK Investigational Site, Iowa City

53792

GSK Investigational Site, Madison

80528

GSK Investigational Site, Fort Collins

92103

GSK Investigational Site, San Diego

90095-1752

GSK Investigational Site, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY